HOME >> BIOLOGY >> NEWS
Echinacea Symposium Presents New Research On Chernobyl Victims

The results from a long-term clinical study in the Ukraine on the use of Echinacea to treat victims of the Chernobyl disaster is among the new studies to be presented at the 1999 International Echinacea Symposium June 3-5 in Kansas City, MO.

Dr. Victoriya F. Pochernyayeva, a leading researcher from Ukraine and the former Soviet Union, will review the results of her long-term studies including:

  • An analysis of how effectively Echinacea purpurea, consumed as a food additive in fruit juices and other non-alcoholic and alcoholic drinks, protects people who are exposed to radiation. Based on her findings, Dr. Pochernyayeva recommends ways Echinacea purpurea food additives can be used most effectively to safeguard a population that is facing high levels of radiation exposure;
  • A study of how Echinacea purpurea can protect the male reproductive system from the effects of radiation;
  • A study of how effectively Echinacea purpurea can protect organs and tissues from radiation damage.

The world's leading Echinacea researcher, Dr. Rudolf Bauer, is the keynote speaker. Dr. Bauer, professor at the Institute of Pharmaceutical Biology, University of Dusseldorf, has published more than 100 research papers and has edited a book on Echinacea. He's currently researching the quality aspects of Echinacea preparations, constituents and pharmacological activity of Echinacea species.

The event is hosted by the American Herbal Products Association. Sponsors include Nature's Way, Botanicals International, Bioforce USA, Finzelberg North America, Rexall Sundown, Indena USA, and Plantation Medicinals.

Who: Some 150 researchers, scientists and other professionals from the herbal industry.

What: 1999 International Echinacea Symposium

Where: Ritz-Carlton, Kansas City, MO.

When: June 3-5, 1999

Why: To present the latest clinical research, and learn about the
'"/>

Contact: Brian Ruberry
br@rubcomm.com
301-947-1662
American Herbal Products Association
11-May-1999


Page: 1 2 3

Related biology news :

1. NIH funds botanical center in Iowa to study health effects of Echinacea and St. Johns wort
2. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
6. Health of worlds sea lions the focus of Wakefield Symposium
7. Chemical signals health of brain cells Symposium
8. Final Alert: 16th EORTC NCI AACR Symposium
9. 16th EORTC NCI AACR Symposium
10. Symposium to tackle questions of genetic engineering and biodiversity
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... and HAMILTON, Bermuda , Feb. ... ADXS ) and SELLAS Life ... on developing cancer immunotherapies, today announced that Advaxis ... novel cancer immunotherapy agent using Advaxis, proprietary ... WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change ... advocacy, and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. ...
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
Breaking Biology Technology:
Cached News: